Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A1c

References

• The Diabetes Controlb and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–9
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes Care 1993;16:1517–20
   PubMed Web of Science ®Google Scholar
• Position Statement. Diabetes Care 1995;18(Suppl 1):8–15
   Google Scholar
• Hoelzel W, Miedema K. Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996;9:62–7
   Google Scholar
• Kobold U, Jeppsson J-O, Dülffer T, Finke A, Hoelzel W, Miedema K. Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem 1997;43: 1944–51
   PubMed Web of Science ®Google Scholar
• http://web.missouri.edu/~diabetes//ngsp/index.html (Accessed September 14th 2002)
   Google Scholar
• Myers GL, Kimberly MM, Waymack PP, Smith SJ, Cooper GR, Sampson EJ. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000;46;1762–72
   PubMed Web of Science ®Google Scholar
• Little RR, Rohlfing CL, Wiedmeyer H-S, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985–92
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Intensive blood group with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837–53
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352: 854–65
   PubMed Web of Science ®Google Scholar
• Marshall SM, Barth JH. Standardization of HbA1c measurements: a consensus statement. Ann Clin Biochem 2000;37:45–6
   PubMed Web of Science ®Google Scholar
• Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436–72
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Tests of Glycemia in Diabetes. Diabetes Care 2003;26(Suppl 1):S106–8
   PubMedGoogle Scholar
• Koch DD, Peters T. Selection and evaluation of methods. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 3rd edn, Ch 13. Philadelphia: W.B. Saunders, 1999:320
   Google Scholar
• Kenny D, Fraser CG, Hyltoft Petersen P, Kallner A. Consensus agreement. Scand J Clin Lab Invest 1999;59:585
   Web of Science ®Google Scholar
• Massart DL, Diijkstra A, Kaufman L. Evaluation and optimization of laboratory methods and analytical procedures: a survey of statistical and mathematical techniques. Amsterdam: Elsevier, 1978:157–64
   Google Scholar
• Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev 2001;17: 94–8
   PubMed Web of Science ®Google Scholar
• Rohlfing C, Wiedmeyer H-S, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116–18
   PubMed Web of Science ®Google Scholar
• Fraser CG, ed. Biological Variation: from Principles to Practice. Washington, DC: American Association of Clinical Chemistry Press, 2001:18
   Google Scholar
• Phillipou G, Phillips PJ. Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993;39:2305–8
   PubMed Web of Science ®Google Scholar
• Howey JEA, Bennet WM, Browning MCK, Jung RT, Fraser CG. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation. Diabetic Med 1989;6:793–6
   PubMed Web of Science ®Google Scholar
• Larsen ML, Fraser CG, Petersen PH. A comparison of analytical goals for haemoglobin A1c assays derived using different strategies. Ann Clin Biochem 1991;28: 272–8
   PubMed Web of Science ®Google Scholar
• Cembrowski GS. The pursuit of quality in clinical laboratory analyses. Clin Chem 1990;36:1602–4
   PubMed Web of Science ®Google Scholar
• Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 1999;36:451–9
   PubMed Web of Science ®Google Scholar
• Harris EK. Some theory of reference values. II. Comparison of some statistical models of intraindividual variation in blood constituents. Clin Chem 1976;22:1343–50
   PubMed Web of Science ®Google Scholar
• Kroll MH. Biological variation of glucose and insulin includes a deterministic chaotic component. BioSystems 1999;50:189–201
   PubMed Web of Science ®Google Scholar
• http://www.westgard.com/essay44.htm (Accessed September 14th 2002)
   Google Scholar
• Instruction Manual Bio-Rad™ Variant II Hemoglobin A1c Program page 22
   Google Scholar
• Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes Care, 2003;26(Suppl 1): S38
   Google Scholar
• Reynolds TM, Twomey P, Wierzbicki AS. Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes. J Cardiovasc Risk 2002;9:183–90
   PubMedGoogle Scholar
• Rofling CL, Wiedmeyer H-M, Little RR, England JD, Tennill A. Goldstein DE. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25: 275–8
   PubMed Web of Science ®Google Scholar
• Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2003;in press
   Google Scholar
• Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321: 405–12
   PubMed Web of Science ®Google Scholar
• Jørgensen LGM, Brandlund I, Stahl M, Hyltoft Petersen P, Iversen S, Klitgaard N, De Fine Olivarius N. Upper reference limit, analytical quality specifications and clinical use of haemoglobin A1C. Scand J Clin Lab Invest 2002;62: 609–22
   PubMed Web of Science ®Google Scholar